Douglas J. Swirsky, President and CEO at REXAHN PHARMACEUTICALS, INC. (RNN), bought 50,000 shares at $0.63 ($32K) on 2019-01-29, disclosed to the SEC on 2019-01-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MXCT | SELL | 2025-03-20 | $22K | — | Filing → |
| CLRB | BUY | 2021-09-14 | $26K | — | Filing → |
| GNVC | BUY | 2016-09-16 | $5K | — | Filing → |